ARTICLE | Clinical News
BioAstin astaxanthin: Marketed as a dietary supplement
September 10, 2001 7:00 AM UTC
Preliminary results from a double-blind, placebo-controlled U.S. study showed that BioAstin did not significantly reduce DOMS compared to placebo. However CYAN said that treatment with BioAstin did re...